1-10 of 10
Dagmar Beier
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Transcriptional Profiles of CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cell Lines Suggest Different Cells of Origin

Claudio Lottaz, Dagmar Beier, Katharina Meyer, Praveen Kumar, Andreas Hermann, Johannes Schwarz, Markus Junker, Peter J. Oefner, Ulrich Bogdahn, Jörg Wischhusen, Rainer Spang, Alexander Storch, Christoph P. Beier
Journal: Cancer Research
Cancer Res (2010) 70 (5): 2030–2040.
https://doi.org/10.1158/0008-5472.CAN-09-1707
Published: 28 February 2010
View article titled, Transcriptional Profiles of CD133<sup>+</sup> and CD133<sup>−</sup> Glioblastoma-Derived Cancer Stem Cell Lines Suggest Different Cells of Origin
Open the PDF for Transcriptional Profiles of CD133<sup>+</sup> and CD133<sup>−</sup> Glioblastoma-Derived Cancer Stem Cell Lines Suggest Different Cells of Origin in another window
Includes: Supplementary data
Journal Articles

Immunoselection of Breast and Ovarian Cancer Cells with Trastuzumab and Natural Killer Cells: Selective Escape of CD44high/CD24low/HER2low Breast Cancer Stem Cells

Florian Reim, Yvonne Dombrowski, Cathrin Ritter, Mathias Buttmann, Sebastian Häusler, Monika Ossadnik, Mathias Krockenberger, Dagmar Beier, Christoph P. Beier, Johannes Dietl, Jürgen C. Becker, Arnd Hönig, Jörg Wischhusen
Journal: Cancer Research
Cancer Res (2009) 69 (20): 8058–8066.
https://doi.org/10.1158/0008-5472.CAN-09-0834
Published: 14 October 2009
View article titled, Immunoselection of Breast and Ovarian Cancer Cells with Trastuzumab and Natural Killer Cells: Selective Escape of CD44<sup>high</sup>/CD24<sup>low</sup>/HER2<sup>low</sup> Breast Cancer Stem Cells
Open the PDF for Immunoselection of Breast and Ovarian Cancer Cells with Trastuzumab and Natural Killer Cells: Selective Escape of CD44<sup>high</sup>/CD24<sup>low</sup>/HER2<sup>low</sup> Breast Cancer Stem Cells in another window
Journal Articles

In Response

Dagmar Beier, Deepu R. Pillai, Christoph P. Beier
Journal: Cancer Research
Cancer Res (2009) 69 (15): 6365.
https://doi.org/10.1158/0008-5472.CAN-09-1405
Published: 29 July 2009
View article titled, In Response
Open the PDF for In Response in another window
Journal Articles

Temozolomide Preferentially Depletes Cancer Stem Cells in Glioblastoma

Dagmar Beier, Stefanie Röhrl, Deepu R. Pillai, Stefanie Schwarz, Leoni A. Kunz-Schughart, Petra Leukel, Martin Proescholdt, Alexander Brawanski, Ulrich Bogdahn, Ariane Trampe-Kieslich, Bernd Giebel, Jörg Wischhusen, Guido Reifenberger, Peter Hau, Christoph P. Beier
Journal: Cancer Research
Cancer Res (2008) 68 (14): 5706–5715.
https://doi.org/10.1158/0008-5472.CAN-07-6878
Published: 15 July 2008
View article titled, Temozolomide Preferentially Depletes Cancer Stem Cells in Glioblastoma
Open the PDF for Temozolomide Preferentially Depletes Cancer Stem Cells in Glioblastoma in another window
Includes: Supplementary data
Journal Articles

Temozolomide selectively eliminates cancer stem cells in glioblastoma

Christoph Beier, Dagmar Beier, Rohrl Stefanie, Deepu Pillai, Schwarz Stefanie, Leonie Kunz-Schughart, Martin Proeschold, Alexander Brawanski, Ulrich Bogdahn, Jorg Wischhusen, Guido Reifenberger, Peter Hau
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 3208.
Published: 01 May 2008
View article titled, Temozolomide selectively eliminates cancer stem cells in glioblastoma
Journal Articles

The role of matrix metalloproteinase-2 in transforming growth factor-beta2 mediated glioma cell migration

Peter Hau, Fuesun Arslan, Anja-Kathrin Bosserhoff, Anett Doerfelt, Dagmar Beier, Petra Leukel, Thomas Nickl-Jockschat, Ulrich Bogdahn
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 3527.
Published: 01 May 2008
View article titled, The role of matrix metalloproteinase-2 in transforming growth factor-beta2 mediated glioma cell migration
Journal Articles

CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cells Show Differential Growth Characteristics and Molecular Profiles

Dagmar Beier, Peter Hau, Martin Proescholdt, Annette Lohmeier, Jörg Wischhusen, Peter J. Oefner, Ludwig Aigner, Alexander Brawanski, Ulrich Bogdahn, Christoph P. Beier
Journal: Cancer Research
Cancer Res (2007) 67 (9): 4010–4015.
https://doi.org/10.1158/0008-5472.CAN-06-4180
Published: 04 May 2007
View article titled, CD133<sup>+</sup> and CD133<sup>−</sup> Glioblastoma-Derived Cancer Stem Cells Show Differential Growth Characteristics and Molecular Profiles
Open the PDF for CD133<sup>+</sup> and CD133<sup>−</sup> Glioblastoma-Derived Cancer Stem Cells Show Differential Growth Characteristics and Molecular Profiles in another window
Includes: Supplementary data
Journal Articles

Regeneration and Tolerance Factor: A Novel Mediator of Glioblastoma-Associated Immunosuppression

Patrick Roth, Steffen Aulwurm, Isabella Gekel, Dagmar Beier, Roxanne G. Sperry, Michel Mittelbronn, Richard Meyermann, Kenneth D. Beaman, Michael Weller, Jörg Wischhusen
Journal: Cancer Research
Cancer Res (2006) 66 (7): 3852–3858.
https://doi.org/10.1158/0008-5472.CAN-05-3062
Published: 03 April 2006
View article titled, Regeneration and Tolerance Factor: A Novel Mediator of Glioblastoma-Associated Immunosuppression
Open the PDF for Regeneration and Tolerance Factor: A Novel Mediator of Glioblastoma-Associated Immunosuppression in another window
Journal Articles

Longterm treatment with temozolomide in high-grade gliomas is feasible and leads to longterm survival in a significant subset of patients

Dagmar Beier, Peter Hau, Tanja Jauch, Dorothee Koch, Tom Hundsberger, S. Schuth, U. Bogdahn
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1355.
Published: 01 May 2005
View article titled, Longterm treatment with temozolomide in high-grade gliomas is feasible and leads to longterm survival in a significant subset of patients
Journal Articles

Adjuvant chemotherapy with temozolomide and liposomal doxorubicine in the first-line therapy of patients with glioblastoma - a phase-II trial

Peter Hau, Tanja Jauch, Ulrike Baumgart, Dagmar Beier, Susanne Gänβbauer, Horst Koch, Cäcilia Wismeth, Andreas Steinbrecher, Ulrich Bogdahn
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1354–1355.
Published: 01 May 2005
View article titled, Adjuvant chemotherapy with temozolomide and liposomal doxorubicine in the first-line therapy of patients with glioblastoma - a phase-II trial